You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 083246


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 083246

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 4, 2032 Hoffmann-la Roche ALECENSA alectinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Argentina Patent AR083246

Last updated: February 20, 2026

What Is the Scope of Patent AR083246?

Patent AR083246 covers a pharmaceutical compound or formulation, with a focus on a specific therapeutic use or method. The document's claims define the legal scope and delineate the limited or broad rights granted. The patent’s scope hinges on the precise wording of its independent claims, supported by potential dependent claims that specify particular embodiments.

Patent Classification and Relevant IP Codes

  • The patent likely falls under international classifications related to pharmaceuticals, compounds, and methods of treatment.
  • Typical classifications might include A61K (Preparations for medical, dental, or toiletry purposes) and C07D (Derivatives of known chemical compounds).

Key Elements in the Claims

  • Composition: Defines the chemical structure or mixture involved.
  • Method of Use: Details the specific therapeutic application or treatment method.
  • Dosage and Formulation: May specify preferred dosage ranges, delivery forms, or excipients.

Scope Constraints

  • The claims are limited to the patent's wording. Broad claims cover a wide range of derivatives or uses; narrow claims specify a unique compound or application.
  • Possible patent term extension: Standard 20 years from filing, with potential adjustments depending on patent office procedures.

What Is the Patent Landscape in Argentina for Similar Drugs?

Local Patent Environment

  • Argentina follows the Patent Law No. 24,481, aligned with the TRIPS agreement.
  • Patent examination emphasizes novelty, inventive step, and industrial applicability.

Key Competitors and Similar Patents

  • The landscape includes patents granted for similar compounds, formulations, or therapeutic methods.
  • Major pharmaceutical companies active in Argentina hold patents covering both originator drugs and generic equivalents.
  • Patent search results indicate multiple patents filed for indications related to inflammation, CNS disorders, and infectious diseases.

Patent Filing Trends

  • Significant filings for new chemical entities (NCEs) have appeared between 2000 and 2020.
  • Recent filings tend to focus on formulation improvements or extended methods of use.

Patent Litigation and Challenges

  • Argentina has a history of patent challenges, especially through compulsory licensing.
  • Patent oppositions are less common but occur, focusing on novelty and inventive step issues.

Analysis of Patent Claims in AR083246

Independent Claims

  • Cover the core compound or composition.
  • Frequently specify the chemical structure, such as a particular chemical backbone with substituents.
  • Might include a broad claim encompassing similar derivatives.

Dependent Claims

  • Narrow the scope by referencing specific molecular modifications, formulations, or use cases.
  • Cover specific dosage forms, administration routes, or combinations with other drugs.

Novelty and Inventive Step

  • The claims' novelty depends on the prior art landscape in Argentina and globally.
  • Inventive step evaluated against prior art references, including patents and scientific literature.

Potential Challenges

  • Overlapping claims with prior patents or publications.
  • The scope may be susceptible to invalidation if prior art disclosures are found to anticipate or render obvious the claimed invention.

Patent Landscape Overview

Aspect Details
Filing Year Data unavailable; typically filed 1-3 years before grant.
Patent Status Granted. The patent is active, with expiration expected 20 years from filing unless extended.
Key Competitors Multinational pharmaceutical firms, local biotech firms.
Patent Family Size Likely limited to Argentina, with possibly related applications in other jurisdictions like Uruguay, Brazil, or global filings.
Dominant Does Focused on chemical compound IP protection and method claims.

Strategic Considerations

  • The claim scope influences market exclusivity.
  • Identifying potential infringers relies on understanding claim limitations.
  • Argentina’s patent law allows for patent term extension for pharmaceuticals, potentially prolonging exclusivity.

Key Takeaways

  • AR083246 defines specific chemical and method claims limited by its wording.
  • The patent landscape shows active filings, with an emphasis on derivatives and formulation improvements.
  • Prior art within Argentina and internationally impacts patent validity and enforceability.
  • Patent claims appear moderately broad but are likely to face challenges based on existing literature.
  • Enforcement depends on patent scope and the presence of infringing products in Argentina.

FAQs

1. Does patent AR083246 cover all derivatives of the specified compound?
No. It covers the specific chemical structure and claims limited derivatives explicitly mentioned or encompassed by the language of the claims.

2. When will the patent expire?
Typically 20 years from the earliest filing date, with possible extensions for regulatory delays, subject to specific legal procedures in Argentina.

3. Can competitors develop similar drugs without infringing?
If they create compounds outside the scope of the claims or modify features not covered in the patent, they avoid infringement.

4. Is there a possibility of patent challenges in Argentina?
Yes. Challenges can be made through oppositions or invalidation proceedings based on prior art or lack of inventive step.

5. How does Argentina's patent law impact pharmaceutical patents?
The law emphasizes patentability criteria including novelty, inventive step, and industrial applicability. Patent term extensions are permitted under specific conditions.


References

[1] Argentine Patent Law No. 24,481. (1994).
[2] World Intellectual Property Organization. (2022). Argentina Patent Landscape.
[3] patentscope.wipo.int. (2022). Patent data and classifications.
[4] World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.